posted on 2014-05-16, 15:14authored byJoanna Kathryn Fiona Boyd
IgA nephropathy is a common kidney disease classically presenting in the second to
third decade with episodic haematuria following mucosal infection. Up to a third of
patients will develop progressive renal failure requiring renal replacement therapy.
IgA nephropathy is diagnosed on renal biopsy by finding deposits containing the
immunoglobulin IgA in the renal mesangium. Deposited IgA has particular
characteristics: it is typically polymeric, of the IgA1 subtype and the IgA1 hinge region
tends to be poorly galactosylated when compared to circulating IgA1 from healthy
subjects.
IgA is synthesised by IgA-committed B cells usually in response to mucosal antigen
encounter. Differential glycosylation of the IgA1 hinge region appears to be important
in the normal human immune response and is controlled by specific glycosyl- and
sialyl-transferases. Abnormalities in glycosyl- or sialyltransferase expression are
therefore predicted to play a role in the generation of poorly galactosylated IgA1
which deposits in the renal mesangium of patients with IgA nephropathy.
My aim was to define glycosyltransferase expression in circulating IgA-secreting B cells
from patients and compare expression patterns with healthy subjects. We isolated
IgA[superscript +] plasmablasts and memory B cells from peripheral blood samples by flow
cytometry and interrogated them by quantitative PCR for mRNA expression of the
glycosyltransferase C1GalT1 and its molecular chaperone Cosmc, both known to be
important in IgA1 hinge region galactosylation.
We found that IgA+ plasmablasts but not IgA[superscript +] memory B cells from patients tended to
express higher levels of both C1GalT1 and Cosmc when compared to healthy subjects.
This confirms previous suggestions that an enzyme abnormality is not global and we
show that it may be localised to the IgA[superscript +] plasmablast population. Decreased IgA1
hinge region galactosylation would be predicted to be associated with lower levels of
C1GalT1 expression and we speculate that our results demonstrate a compensatory
response to poor galactosylation.
History
Supervisor(s)
Barratt, Jonathan; Molyneux, Karen
Date of award
2014-04-01
Author affiliation
Department of Infection, Immunity and Inflammation